Literature DB >> 20191512

Malignancy risk in patients with giant cell arteritis: a population-based cohort study.

Tanaz A Kermani1, Valentin S Schäfer, Cynthia S Crowson, Gene G Hunder, Sherine E Gabriel, Steven R Ytterberg, Eric L Matteson, Kenneth J Warrington.   

Abstract

OBJECTIVE: To determine the incidence of cancer in a population-based cohort of patients with giant cell arteritis (GCA) compared with age- and sex-matched referent subjects.
METHODS: Using the resources of the Rochester Epidemiology Project, all incident cases of GCA diagnosed between January 1, 1950 and December 31, 2004 were identified. For each GCA patient, 2 subjects without GCA of the same sex and similar age and length of medical history were selected. Diagnosis of malignancy was made by histopathology. Patients were followed until death, last contact, or December 31, 2006.
RESULTS: Our study included 204 GCA patients and 407 non-GCA subjects. The GCA cohort had 163 (79%) women and 41 (21%) men, a mean +/- SD age of 76.0 +/- 8.2 years, and a median followup of 7.7 years. The non-GCA cohort consisted of 325 (80%) women and 82 (20%) men, a mean +/- SD age of 75.6 +/- 8.4 years, and a median followup of 8.1 years. During followup, 46 GCA patients and 76 non-GCA subjects developed cancer (hazard ratio [HR] 1.26, 95% confidence interval [95% CI] 0.87-1.83). Adjustment for smoking did not alter the results. The 1-, 10-, and 20-year cumulative incidences of any malignancy were 5.9%, 33.6%, and 50.0% among GCA patients and 2.6%, 27.0%, and 47.0% among non-GCA patients, respectively. There were no differences in hematologic or solid malignancies between both groups. Colon cancer appeared more commonly in the GCA group (P = 0.07). Mortality following cancer was similar in both cohorts (HR 0.80, 95% CI 0.52-1.24).
CONCLUSION: GCA patients are not at an increased risk of first cancer after diagnosis.

Entities:  

Mesh:

Year:  2010        PMID: 20191512      PMCID: PMC2874240          DOI: 10.1002/acr.20062

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  25 in total

1.  The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis.

Authors:  G G Hunder; D A Bloch; B A Michel; M B Stevens; W P Arend; L H Calabrese; S M Edworthy; A S Fauci; R Y Leavitt; J T Lie
Journal:  Arthritis Rheum       Date:  1990-08

2.  A population-based case-control study of temporal arteritis: evidence for an association between temporal arteritis and degenerative vascular disease?

Authors:  E B Machado; S E Gabriel; C M Beard; C J Michet; W M O'Fallon; D J Ballard
Journal:  Int J Epidemiol       Date:  1989-12       Impact factor: 7.196

Review 3.  Rochester Epidemiology Project: a unique resource for research in the rheumatic diseases.

Authors:  Hilal Maradit Kremers; Cynthia S Crowson; Sherine E Gabriel
Journal:  Rheum Dis Clin North Am       Date:  2004-11       Impact factor: 2.670

4.  Acute myeloid leukemia associated with necrotizing temporal arteritis.

Authors:  Kenneth J Warrington; Bernd W Scheithauer; Clement J Michet
Journal:  J Rheumatol       Date:  2003-04       Impact factor: 4.666

5.  Nonfatal cancer preceding Parkinson's disease: a case-control study.

Authors:  Alexis Elbaz; Brett J Peterson; Ping Yang; Jay A Van Gerpen; James H Bower; Demetrius M Maraganore; Shannon K McDonnell; J Eric Ahlskog; Walter A Rocca
Journal:  Epidemiology       Date:  2002-03       Impact factor: 4.822

6.  No increased frequency of malignant neoplasms in polymyalgia rheumatica and temporal arteritis. A prospective longitudinal study of 398 cases and matched population controls.

Authors:  Geirmund Myklebust; Tom Wilsgaard; Bjarne Koster Jacobsen; Jan Tore Gran
Journal:  J Rheumatol       Date:  2002-10       Impact factor: 4.666

7.  Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period.

Authors:  Carlo Salvarani; Cynthia S Crowson; W Michael O'Fallon; Gene G Hunder; Sherine E Gabriel
Journal:  Arthritis Rheum       Date:  2004-04-15

8.  Cancer in association with polymyalgia rheumatica and temporal arteritis.

Authors:  H J Haga; G E Eide; J Brun; A Johansen; F Langmark
Journal:  J Rheumatol       Date:  1993-08       Impact factor: 4.666

9.  C-reactive protein and the risk of incident colorectal cancer.

Authors:  Thomas P Erlinger; Elizabeth A Platz; Nader Rifai; Kathy J Helzlsouer
Journal:  JAMA       Date:  2004-02-04       Impact factor: 56.272

10.  Myelodysplastic and myeloproliferative syndromes associated with giant cell arteritis and polymyalgia rheumatica: a coincidental coexistence or a causal relationship?

Authors:  G Espinosa; J Font; F J Muñoz-Rodríguez; R Cervera; M Ingelmo
Journal:  Clin Rheumatol       Date:  2002-08       Impact factor: 2.980

View more
  14 in total

1.  Solid malignancies among etanercept-treated patients with granulomatosis with polyangiitis (Wegener's): long-term followup of a multicenter longitudinal cohort.

Authors:  Francisco Silva; Philip Seo; Darrell R Schroeder; John H Stone; Peter A Merkel; Gary S Hoffman; Robert Spiera; Jodi K Sebastian; John C Davis; E William St Clair; Nancy B Allen; W Joseph McCune; Steven R Ytterberg; Ulrich Specks
Journal:  Arthritis Rheum       Date:  2011-08

2.  Malignancy risk in vasculitis.

Authors:  Tanaz A Kermani; Kenneth J Warrington; Shreyasee Amin
Journal:  Ther Adv Musculoskelet Dis       Date:  2011-02       Impact factor: 5.346

Review 3.  The diagnosis and treatment of giant cell arteritis.

Authors:  Thomas Ness; Thorsten A Bley; Wolfgang A Schmidt; Peter Lamprecht
Journal:  Dtsch Arztebl Int       Date:  2013-05-24       Impact factor: 5.594

4.  Cancer preceding giant cell arteritis: a case-control study.

Authors:  Tanaz A Kermani; Valentin S Schäfer; Cynthia S Crowson; Gene G Hunder; Steven R Ytterberg; Eric L Matteson; Sherine E Gabriel; Kenneth J Warrington
Journal:  Arthritis Rheum       Date:  2010-06

5.  Cardiac and thromboembolic complications and mortality in patients undergoing total hip and total knee arthroplasty.

Authors:  Jasvinder A Singh; Matthew R Jensen; William Scott Harmsen; Sherine E Gabriel; David G Lewallen
Journal:  Ann Rheum Dis       Date:  2011-10-21       Impact factor: 19.103

Review 6.  Giant cell arteritis and polymyalgia rheumatica: an update.

Authors:  Miguel A González-Gay; Trinitario Pina
Journal:  Curr Rheumatol Rep       Date:  2015-02       Impact factor: 4.592

7.  Incidence of malignancy in Takayasu arteritis in Korea.

Authors:  Jin Kyun Park; In Ah Choi; Eun Young Lee; Yeong Wook Song; Eun Bong Lee
Journal:  Rheumatol Int       Date:  2013-10-29       Impact factor: 2.631

Review 8.  TNF-α blocker therapy and solid malignancy risk in ANCA-associated vasculitis.

Authors:  Francisco Silva; Marcela Cisternas; Ulrich Specks
Journal:  Curr Rheumatol Rep       Date:  2012-12       Impact factor: 4.592

9.  Giant cell temporal arteritis associated with overlying basal cell carcinoma: co-incidence or connection?

Authors:  Etienne Mahe; Dina El Demellawy; Anita Bane; Salem Alowami
Journal:  Rare Tumors       Date:  2012-09-20

10.  Is cancer associated with polymyalgia rheumatica? A cohort study in the General Practice Research Database.

Authors:  Sara Muller; Samantha L Hider; John Belcher; Toby Helliwell; Christian D Mallen
Journal:  Ann Rheum Dis       Date:  2013-07-10       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.